Skip to main content
Equibles
YCBD logo

YCBD · cbdMD, Inc.

Track YCBD — free

Use YCBD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about YCBD

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.50 -0.07 (-12.25%) At close · Aug 14
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These and other factors raise substantial doubt about the Company's ability to continue as a going concern within twelve months after the date that these financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$5.93M
Shares
11.21M

cbdMD, Inc. Earnings Call Transcripts

Every quarterly earnings call for cbdMD, Inc. (YCBD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲2079.2% $10.15M $12.93M '20 Q1 19-12-31 ▲66.8% $9.40M $14.88M '20 Q2 20-04-06 ▲32.9% $10.64M −$8.95M '20 Q3 20-08-04 ▲25.5% $11.80M −$12.51M '21 Q2 21-05-12 ▼0.7% $10.56M $1.54M '21 Q3 21-08-12 ▼24.4% $9.32M −$19.16M '22 Q1 21-12-31 ▼18.6% $8.59M −$31.63M '22 Q3 22-06-30 ▼19.7% $7.86M −$14.63M '22 Q4 22-09-30 ▼35.2% $6.24M −$1.34M '23 Q2 23-03-31 ▼15.5% $5.17M $459,737 '24 Q3 24-06-30 ▼4.9% $5.11M $15,095 '25 Q1 24-12-31 ▲8.5% $4.75M −$480,757 '25 Q2 25-03-31 LATEST ▲3.6% $4.72M −$679,968 '25 Q4 25-11-25
Earnings call
FY25 · Q4
2025-11-25
cbdMD, Inc. Q4 FY2025 Earnings Call
Positive tone Federal cannabis/hemp executive order Operating loss reduction and financial discipline Oasis beverage brand expansion
Revenue
$4.72M*
▲ 3.6% YoY
Gross margin
58.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q2
2025-03-31
cbdMD, Inc. Q2 FY2025 Earnings Call
Confident tone Liquidity and working capital Herbal Oasis THC seltzer Capital structure reset and NYSE compliance
Revenue
$4.75M
▲ 8.5% YoY
Gross margin
62.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-12-31
cbdMD, Inc. Q1 FY2025 Earnings Call
Confident tone Liquidity and working capital Product innovation pipeline Oasis social tonic beverage launch
Revenue
$5.11M
▼ 4.9% YoY
Gross margin
66.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-06-30
cbdMD, Inc. Q3 FY2024 Earnings Call
Positive tone NYSE American listing compliance Revenue decline and profitability progress Capital structure and balance sheet
Revenue
$5.17M
▼ 15.5% YoY
Diluted EPS
$-1.20
Gross margin
65.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-03-31
cbdMD, Inc. Q2 FY2023 Earnings Call
Revenue
$6.24M
▼ 35.2% YoY
Diluted EPS
$-13.92
Gross margin
64.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-09-30
cbdMD, Inc. Q4 FY2022 Earnings Call
Revenue
$7.86M*
▼ 19.7% YoY
Gross margin
63.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-06-30
cbdMD, Inc. Q3 FY2022 Earnings Call
Revenue
$8.59M
▼ 18.6% YoY
Diluted EPS
$-198.48
▼ 2856.7% YoY
Gross margin
69.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-12-31
cbdMD, Inc. Q1 FY2022 Earnings Call
Revenue
$9.32M
▼ 24.4% YoY
Diluted EPS
$-126.00
Gross margin
53.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q3
2021-08-12
cbdMD, Inc. Q3 FY2021 Earnings Call
Revenue
$10.56M
▼ 0.7% YoY
Diluted EPS
$7.20
Gross margin
68.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-05-12
cbdMD, Inc. Q2 FY2021 Earnings Call
Revenue
$11.80M
▲ 25.5% YoY
Diluted EPS
$-86.40
▼ 160% YoY
Gross margin
69.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q3
2020-08-04
cbdMD, Inc. Q3 FY2020 Earnings Call
Revenue
$10.64M
▲ 32.9% YoY
Diluted EPS
$0.00
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-04-06
cbdMD, Inc. Q2 FY2020 Earnings Call
Revenue
$9.40M
▲ 66.8% YoY
Diluted EPS
$144.00
Gross margin
70.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2019-12-31
cbdMD, Inc. Q1 FY2020 Earnings Call
Revenue
$10.15M
▲ 2079.2% YoY
Diluted EPS
$162.00
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–13 of 13 earnings calls
Key facts CIK 1644903 CUSIP 12482W408 13F (30d) 25 filings 25 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)